Gerald Carlson
Vorstandsvorsitzender bei Phibro Animal Health (Belgium) SA
Profil
Gerald K.
Carlson is currently the Chief Executive Officer at Phibro Animal Health (Belgium) SA. Previously, he worked as the Chief Operating Officer & Director at Phibro Animal Health Corp.
from 2014 to 2016.
He also worked as the Senior VP-Corporate Planning & Development at Ecolab, Inc. in 1998 and as the Commissioner-Trade & Development at State of Minnesota from 1999 to 2001.
Aktive Positionen von Gerald Carlson
| Unternehmen | Position | Beginn |
|---|---|---|
Phibro Animal Health (Belgium) SA
 Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Vorstandsvorsitzender | 08.06.2011 |
Ehemalige bekannte Positionen von Gerald Carlson
| Unternehmen | Position | Ende |
|---|---|---|
| State of Minnesota | Corporate Officer/Principal | 01.01.2001 |
| ECOLAB INC. | Corporate Officer/Principal | 01.10.1998 |
| PHIBRO ANIMAL HEALTH CORPORATION | Vorstandsvorsitzender | 01.03.2014 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PHIBRO ANIMAL HEALTH CORPORATION | Health Technology |
| ECOLAB INC. | Process Industries |
| Private Unternehmen | 2 |
|---|---|
Phibro Animal Health (Belgium) SA
Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Process Industries |
| State of Minnesota | Government |
